Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
ACS Biomaterials Science & Engineering|January 16, 2021
Modular Immune Organoids with Integrin Ligand Specificity Differentially Regulate Ex Vivo B Cell ActivationAlberto Purwada, Shivem B Shah, Wendy Beguelin, et al.Breast Cancer Research and Treatment|September 18, 2009
Transactivation of ErbB-2 induced by tumor necrosis factor alpha promotes NF-kappaB activation and breast cancer cell proliferationMartín A Rivas, Mercedes Tkach, Wendy Beguelin, et al.Molecular and Cellular Biology|December 24, 2008
Activation of Stat3 by heregulin/ErbB-2 through the co-option of progesterone receptor signaling drives breast cancer growthCecilia J Proietti, Cinthia Rosemblit, Wendy Beguelin, et al.Experimental Cell Research|December 7, 2007
TNF alpha acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-kappa B-dependent pathwaysMartín A Rivas, Romina P Carnevale, Cecilia J Proietti, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 4, 2012
Targeting Stat3 induces senescence in tumor cells and elicits prophylactic and therapeutic immune responses against breast cancer growth mediated by NK cells and CD4+ T cellsMercedes Tkach, Lorena Coria, Cinthia Rosemblit, et al.BMC Cancer|February 24, 2012
Clinical relevance of ErbB-2/HER2 nuclear expression in breast cancerRoxana Schillaci, Pablo Guzmán, Florencia Cayrol, et al.Endocrine-Related Cancer|January 19, 2013
p42/p44 MAPK-mediated Stat3Ser727 phosphorylation is required for progestin-induced full activation of Stat3 and breast cancer growthMercedes Tkach, Cinthia Rosemblit, Martín A Rivas, et al.Science Translational Medicine|May 30, 2014
Hematopoietic stem cell origin of BRAFV600E mutations in hairy cell leukemiaStephen S Chung, Eunhee Kim, Jae H Park, et al.The Journal of Clinical Investigation|August 3, 2016
Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphomaMariano G Cardenas, Wenbo Yu, Wendy Beguelin, et al.Pageof 1